Acer Therapeutics Inc. (NASDAQ: ACER) shares jumped more than 10% after the Company announced together with its collaboration partner, RELIEF THERAPEUTICS Holding SA, that the China National Intellectual Property Administration (CNIPA) issued Electronic Patent Certificate ZL202122004991.9 on May 24, 2022,...
Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) share up more than 86% after the Company announced the development of the HYLA™ blood sensor. Without the...
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) has reported results from its biomarker study conducted to evaluate the potential CogniC, NeuroSense’s drug for treatment of Alzheimer’s disease....
Walgreens Boots Alliance’s (NASDAQ: WBA) shares plummeted Thursday amid a decline in demand for Covid-19 vaccines. Nevertheless, the company reported better-than-expected third-quarter earnings. Higher Than...
Omnicom Group Inc. (NYSE: OMC) media services division Omnicom Media Group has partnered with Walmart Connect. Making the announcement at the Cannes Lions Festival of...
Hillstream BioPharma, Inc. (Nasdaq: HILS) today announced that it has begun a collaboration with Sapien Biosciences to evaluate the synergy of HSB-1216 with immune checkpoint...
Disney distributed a memo to employees on Friday, letting them know that the company would be paying for pregnancy-related care even if that meant covering...
F-star Therapeutics, Inc. (NASDAQ: FSTX) has announced that invoX Pharma, subsidiary of Sino Biopharm has plans to acquire the company for USD 7.12 per share. ...
uniQure N.V. (NASDAQ: QURE) share up more than 15% after the Company announced on Thursday new safety and biomarker data from 10 patients enrolled in...
Kazia Therapeutics Limited (NASDAQ: KZIA) shares up about 15% on Friday after the Company announced that the United States Food and Drug Administration (FDA) has...
Day One Biopharmaceuticals (Nasdaq: DAWN) today announced positive initial data from pivotal FIREFLY-1 trial of Tovorafenib. Shares of Day One Biopharmaceuticals (Nasdaq: DAWN) opened 125%...
Cogent Biosciences, Inc. (NASDAQ: COGT) is up more than 60% after the Company announced positive initial data from its ongoing Phase 2 APEX clinical trial...
Moderna, Inc. (NSDAQ: MRNA) has reported new clinical data on Omicron bivalent COVID booster candidate, MRNA-1273.214 and a vaccine candidate targeting the Omicron variant in...
Jul 8, 2022 by MarketDepth